MA41168A - Nouveaux composés antibactériens - Google Patents

Nouveaux composés antibactériens

Info

Publication number
MA41168A
MA41168A MA041168A MA41168A MA41168A MA 41168 A MA41168 A MA 41168A MA 041168 A MA041168 A MA 041168A MA 41168 A MA41168 A MA 41168A MA 41168 A MA41168 A MA 41168A
Authority
MA
Morocco
Prior art keywords
antibacterial compounds
new antibacterial
new
compounds
antibacterial
Prior art date
Application number
MA041168A
Other languages
English (en)
Inventor
De Joannon Alessandra Capezzone
Gaia Corso
Guido Furlotti
Barbara Garofalo
Tommaso Iacoangeli
Gabriele Magaro'
Giorgina Mangano
Rosella Ombrato
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of MA41168A publication Critical patent/MA41168A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MA041168A 2014-12-17 2015-12-10 Nouveaux composés antibactériens MA41168A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14198412 2014-12-17

Publications (1)

Publication Number Publication Date
MA41168A true MA41168A (fr) 2017-10-24

Family

ID=52347083

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041168A MA41168A (fr) 2014-12-17 2015-12-10 Nouveaux composés antibactériens

Country Status (6)

Country Link
US (1) US10369130B2 (fr)
EP (1) EP3233826A1 (fr)
JP (1) JP2017537938A (fr)
AR (1) AR103028A1 (fr)
MA (1) MA41168A (fr)
WO (1) WO2016096631A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41169A (fr) * 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité
ME03738B (fr) 2016-06-08 2021-01-20 Acraf Nouveaux composés antibactériens
BR112022012179A2 (pt) 2019-12-23 2022-09-06 Bristol Myers Squibb Co Compostos de quinazolina substituída úteis como ativadores de célula t
CA3162979A1 (fr) 2019-12-23 2021-07-01 Upender Velaparthi Derives piperazine substitues utiles en tant qu'activateurs de lymphocytes t

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2637591B1 (fr) * 1988-10-11 1992-10-23 Synthelabo Derives de quinoleinone, leur preparation et leur application en therapeutique
FR2655988B1 (fr) 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DK203990D0 (da) * 1990-08-24 1990-08-24 Novo Nordisk As Piperazinylderivater
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
IL105716A0 (en) * 1992-06-08 1993-09-22 Richter Gedeon Vegyeszet Aminopropanol derivatives,their preparation and pharmaceutical compositions containing them
HU215397B (hu) * 1994-08-29 1998-12-28 Richter Gedeon Vegyészeti Gyár Rt. (Piperidino-alkil)-aril-éterek, ezeket tartalmazó gyógyszerkészítmények és eljárás ezek előállítására
EP0925673A1 (fr) 1996-09-09 1999-06-30 Aironet Wireless Communications, Inc. Systeme de telecommunications cellulaires a parametres de transmission de donnees modifies de fa on dynamique
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
DE19900544A1 (de) * 1999-01-11 2000-07-13 Basf Ag Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie
FR2822154B1 (fr) 2001-03-13 2005-10-21 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
MXPA04012440A (es) * 2002-06-12 2005-04-28 Abbott Lab Antagonistas de receptor de hormona concentradora de melanina.
TW200507841A (en) * 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
CA2557541C (fr) * 2004-02-26 2014-12-16 Aska Pharmaceutical Co., Ltd. Derives de pyrimidine
ATE540936T1 (de) * 2004-06-30 2012-01-15 Janssen Pharmaceutica Nv Substituierte 2-alkyl-chinazolinonderivate als parp-hemmer
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
JP5314244B2 (ja) * 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
WO2006072608A2 (fr) * 2005-01-03 2006-07-13 Universitá Degli Studi Di Siena Nouveaux derives d'aryle piperazine presentant une utilite medicale
US7511035B2 (en) * 2005-01-25 2009-03-31 Glaxo Group Limited Antibacterial agents
TWI385164B (zh) * 2005-02-17 2013-02-11 Astellas Pharma Inc Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivatives (II)
WO2006090272A1 (fr) * 2005-02-22 2006-08-31 Warner-Lambert Company Llc Isoquinoline [1,8]naphthyridin-2-ones et composes relatifs destines au traitement de la schizophrenie
JP2009507791A (ja) * 2005-08-29 2009-02-26 メルク エンド カムパニー インコーポレーテッド ナイアシン受容体アゴニスト、このような化合物を含有する組成物、および治療方法
JP5301999B2 (ja) * 2005-10-31 2013-09-25 メルク・シャープ・アンド・ドーム・コーポレーション Cetp阻害薬
EP1903037A1 (fr) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft Dérivés de 1-[(hétéro)aryl]-3-[hétéroaryl-pipéridine-4-yl]thiourée en tant que modulateurs de récepteurs EP2
EP1903038A1 (fr) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft Dérivés N-(1-hetaryl-piperidine-4-yl)-(het)arylamide utilisées comme modulateurs du recepteur EP2
CL2008001002A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
EP1990375B1 (fr) 2007-05-11 2010-07-21 Coatex S.A.S. Utilisation d'une émulsion inverse d'un polymère de l'acrylamide avec un monomère acrylique comme agent stabilisant et réducteur de mousse, dans un procédé de broyage en milieu aqueux de matières minérales et de liants.
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
AU2010206161B2 (en) * 2009-01-21 2014-08-07 Basilea Pharmaceutica Ag Novel bicyclic antibiotics
WO2011057110A1 (fr) * 2009-11-06 2011-05-12 Ruprecht-Karls-Universitat-Heidelberg Agonistes de gpr109a pour le traitement de l'ischémie cérébrale
US9156822B2 (en) 2010-07-02 2015-10-13 The University Of North Carolina At Chapel Hill Functionally selective ligands of dopamine D2 receptors
SG11201401710PA (en) 2011-11-08 2014-09-26 Actelion Pharmaceuticals Ltd 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
TW201326180A (zh) 2011-11-30 2013-07-01 Actelion Pharmaceuticals Ltd 3,7-二取代八氫-2H-吡啶并[4,3-e][1,3]□嗪-2-酮抗生素
US9802929B2 (en) * 2012-11-26 2017-10-31 Shenyang Haiwang Biotechnology Co., Ltd. Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof
MA41169A (fr) * 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité

Also Published As

Publication number Publication date
US10369130B2 (en) 2019-08-06
US20170368017A1 (en) 2017-12-28
EP3233826A1 (fr) 2017-10-25
WO2016096631A1 (fr) 2016-06-23
JP2017537938A (ja) 2017-12-21
AR103028A1 (es) 2017-04-12

Similar Documents

Publication Publication Date Title
MA44050A (fr) Nouveaux composés
MA42293A (fr) Composés antibactériens
MA44233A (fr) Nouveaux composés
ME03419B (fr) Composés dihydroisoquinolinone substitués
HUE050732T2 (hu) Új vegyületek
LT3134402T (lt) 4-amino-imidazochinolino junginiai
EP3334584A4 (fr) Extrudeuse
PT3298027T (pt) Compostos depsipéptidos antelmínticos
MA45221A (fr) Nouveaux composés antibactériens
DK3157926T3 (da) Organiske forbindelser
EP3464336A4 (fr) Composés
EP3288600C0 (fr) Nanofibres antibactériennes
BR112016030730A2 (pt) Composto
LT3362444T (lt) Junginiai
CL2016002165A1 (es) Compuestos de aminocarbonilcarbamato
BR112017014839A2 (pt) novos microbicidas
DK3597189T3 (da) Krystallinske forbindelser
ME03312B (fr) Pyroglutamate de vortioxetine
DK3191466T3 (da) Azetidinyloxyphenylpyrrolidinforbindelser
BR112016018442A2 (pt) agentes antibacterianos
MA49522A (fr) Nouveaux composés de quinoléinone
EP3259254A4 (fr) Composés thérapeutiques
HUE039805T2 (hu) Új szulfonilaminobenzamid vegyületek
DK3347403T3 (da) Polyalkoxyfedtforbindelse
MA41168A (fr) Nouveaux composés antibactériens